P10, Inc. (PX) BCG Matrix

P10, Inc. (PX): BCG Matrix [Apr-2026 Updated]

US | Financial Services | Asset Management | NYSE
P10, Inc. (PX) BCG Matrix

Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets

Diseño Profesional: Plantillas Confiables Y Estándares De La Industria

Predeterminadas Para Un Uso Rápido Y Eficiente

Compatible con MAC / PC, completamente desbloqueado

No Se Necesita Experiencia; Fáciles De Seguir

P10, Inc. (PX) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Honestly, looking at P10, Inc.'s business mix as of late 2025, the picture is sharp: Stars like Private Credit and Secondary Funds are driving that impressive 17% organic FPAUM growth, supported by a rock-solid Cash Cow base of $29.1 billion in Fee-Paying AUM that keeps the lights on with a 47% FRE margin. But you can't ignore the Question Marks, like the new cross-border push, which is likely why Adjusted Net Income slipped 7% in Q3 2025, even as Dogs face the predictable $673 million in fund step-downs. This matrix clearly shows where P10, Inc. is winning big and where it needs to commit serious investment to secure future dominance.



Background of P10, Inc. (PX)

You're looking at P10, Inc. (PX), which operates as a multi-asset class private market solutions provider in the alternative asset management space here in the United States. Honestly, the firm's core business is acting as a bridge, giving institutional investors access to opportunities in private equity, venture capital, impact investing, and private credit, all while keeping a tight focus on the middle and lower-middle markets. That's where they see the structural growth, you know?

P10, Inc. markets its various solutions under several distinct brands, which helps you see where their expertise lies. For instance, their private equity offerings are branded under RCP Advisors, Bonaccord Capital, and P10 Advisors. Then you have TrueBridge for venture capital, Enhanced for impact investing, and a suite of private credit brands including Five Points, Hark Capital, and WTI. The company was founded way back in 1992 and keeps its corporate office in Dallas, Texas.

Let's look at where they stood as of late 2025, based on their third-quarter results released in early November. For Q3 2025, P10, Inc. reported total revenue of $75.9 million, which was a 2% increase year-over-year, though it did miss some analyst expectations slightly. What really stood out, though, was the growth in their core asset base: fee-paying assets under management (FPAUM) surged to $29.1 billion, marking a 17% jump compared to the same time last year. That's a big number, showing strong investor confidence in their platform.

Digging into the earnings, Fee-Related Earnings (FRE) came in at $36.0 million, representing a 3% year-over-year growth, supported by a healthy 47% FRE margin. That margin resilience is key, showing disciplined cost management even as Adjusted Net Income (ANI) dipped to $28.6 million from $30.8 million the year prior, partly due to higher interest costs post-refinancing. On the bright side, Chairman and CEO Luke Sarsfield confirmed they'd exceeded their 2025 organic gross fundraising guidance of $4 billion and now expect to close the year closer to $5 billion raised. That forward momentum is definitely a positive signal for the business.



P10, Inc. (PX) - BCG Matrix: Stars

The Stars quadrant represents P10, Inc.'s business units operating in high-growth markets where the company has secured a leading market share. These areas require significant investment to maintain growth momentum and are positioned to become future Cash Cows as market growth matures.

The overall Fee-Paying Assets Under Management (FPAUM) growth is a key indicator of Star performance. As of the third quarter of 2025, P10, Inc. reported FPAUM of $29.1 billion, marking a 17% increase year-over-year from Q3 2024. This growth trajectory is being actively supported by management, evidenced by raising the full year 2025 organic gross fundraising target to nearly $5 billion from an initial $4 billion guidance.

Here is a breakdown of the key components driving this Star positioning:

  • Private Credit: The segment added $192 million to fee-paying assets under management in the third quarter of 2025. Private credit strategies, including those from Hark Capital, which closed its fourth fund at $645 million in 2024, represent an area of desired expansion for P10, Inc., currently making up less than 20% of total FPAUM.
  • Secondary Market Funds: RCP Advisors' Secondary Opportunity Fund V closed oversubscribed at $1.26 billion in capital commitments, significantly exceeding its initial target of $1 billion.
  • Organic FPAUM Growth: The first three quarters of 2025 saw $4.3 billion in organic fee-paying assets under management raised and deployed, which is a 48% increase compared to the same nine-month period in 2024.
  • Cross-Platform Collaboration: Following the acquisition of Qualitas Funds, the platform's global investor base expanded to over 4,900 investors. This is up from a reported base of more than 3,800 investors as of the first quarter of 2025.

The sustained capital formation momentum is clear when looking at the year-to-date deployment figures for the first nine months of 2025:

Metric Value (as of Q3 2025 or YTD 9M 2025)
Fee-Paying AUM (Q3 2025) $29.1 billion
Year-over-Year FPAUM Growth 17%
Organic Capital Raised/Deployed (9M 2025) $4.3 billion
Organic Fundraising Growth vs. Prior Year (9M) 48% increase
2025 Organic Fundraising Target (Raised) $5 billion

The success in the secondary market, exemplified by the $1.26 billion close of RCP SOF V, directly fuels the high-growth profile of these Stars. This capital requires immediate deployment and support for placement, consuming cash while simultaneously building market share.

You're looking at the engine room of P10, Inc.'s future cash flow, where every dollar invested is aimed at cementing market leadership now. The 17% FPAUM growth rate is the number that separates these units from the more mature Cash Cows.



P10, Inc. (PX) - BCG Matrix: Cash Cows

Cash Cows are the bedrock of P10, Inc. (PX) operations, representing established business units with high market penetration in mature segments, which generate significant, reliable cash flow to fund other parts of the portfolio.

Core Fee-Paying AUM: The stable base of $29.1 billion in FPAUM generates highly predictable, recurring revenue. This figure represents the total Fee-Paying Assets Under Management as of September 30, 2025. This substantial, managed base underpins the stability expected of a Cash Cow, as management fees are directly tied to this capital base.

Fee-Related Earnings (FRE): High-margin business model maintaining a strong 47% FRE margin as of Q3 2025. This margin demonstrates the efficiency of the core business, where revenue generation costs are well-controlled. The Fee-Related Revenue (FRR) for the third quarter of 2025 was $75.9 million, which translated to Fee-Related Earnings (FRE) of $36.0 million for the same period. This high margin is what allows P10, Inc. (PX) to generate surplus cash.

Here's a quick look at the key Q3 2025 financial metrics that define this cash-generating engine:

Metric Value (Q3 2025)
Fee-Paying AUM (FPAUM) $29.1 billion
Fee-Related Revenue (FRR) $75.9 million
Fee-Related Earnings (FRE) $36.0 million
FRE Margin 47%
Quarterly Dividend Declared $0.0375 per share

Long-Duration Capital: Management fees are locked up under long-term contracts, typically 10 to 15 years. While the prompt suggests a range of 10 to 15 years, P10, Inc. (PX) specifically touts long-term fee arrangements with an average duration exceeding seven years. This contractual stickiness reduces near-term uncertainty regarding cash flow projections, allowing for lower promotional spending to maintain market share.

Middle-Market Focus: Strategies in the lower-middle market offer structural advantages and less competition, ensuring durable fees. P10, Inc. (PX) concentrates its investment strategies across private equity, private credit, and venture capital, specifically targeting the middle and lower-middle market segments. This focus is a key differentiator that helps secure high-quality, durable fee streams.

The durability of the fee structure is supported by the following operational characteristics:

  • Core fee rate averaged 103 basis points in Q3 2025.
  • Fee-Related Revenue (FRR) represented 99% of total revenue.
  • Organic fundraising guidance for 2025 was raised to closer to $5 billion.
  • The company maintained operating expenses flat year-over-year at $65.2 million in Q3 2025.


P10, Inc. (PX) - BCG Matrix: Dogs

You're looking at the parts of P10, Inc. (PX) that aren't driving significant growth or cash flow, the classic 'Dogs' in the Boston Consulting Group framework. These are the areas where capital is tied up with minimal return, and honestly, they need careful management to avoid becoming cash traps.

The most concrete example of this drag in Q3 2025 was the capital outflow from mature products. We saw $673 million in fund step-downs and expirations during the third quarter of 2025. This figure, which was higher than Q2's $435 million, represents capital leaving mature funds, which is a natural part of the lifecycle but highlights assets that are past their prime fee-generating stage. Management noted these were slightly above initial expectations for the full year 2025, though they expect a return to historical averages of 5% to 7% in 2026.

Legacy Closed Funds, which are fully deployed and winding down, contribute directly to these step-downs. While the specific revenue from these older vintages isn't broken out separately from the overall Fee-Related Revenue of $75.9 million in Q3 2025, their declining capital base is the source of the $673 million attrition. These units require minimal new investment but still consume administrative resources as they finalize distributions.

For Underperforming Acquisitions, we look at the recent integration of Qualitas Funds. While the acquisition itself is framed as expanding global presence and contributing to the $29.1 billion in Fee-Paying Assets Under Management (FPAUM) as of Q3 2025, the overall Adjusted Net Income (ANI) declined 7% year-over-year to $28.6 million. The CFO specifically cited borrowing costs associated with the Qualitas acquisition as a reason for the ANI decline, suggesting integration or associated financing costs are currently weighing on profitability metrics.

The Low-Yielding Cash position is another area that fits the Dog profile: it's safe but unproductive. P10, Inc. held approximately $40 million in cash and cash equivalents at the end of Q3 2025. This liquidity buffer sits against total outstanding debt of approximately $398 million, which includes a $325 million term loan and $73 million drawn on the revolver as of the quarter's end. While necessary for operations, this cash is not generating returns commensurate with invested capital.

Here's a quick look at the Q3 2025 profitability metrics that reflect the pressure on mature or integrating assets:

Metric Q3 2025 Value Year-over-Year Change
Fee-Related Earnings (FRE) $36.0 million +3%
Adjusted Net Income (ANI) $28.6 million -7%
GAAP Net Income $3.0 million +128%
Fee-Related Earnings Margin (FRE Margin) 47% Down from 48% in Q3 2024

The low GAAP Net Income of $3.0 million compared to the $36.0 million in FRE suggests significant non-fee related expenses or interest costs are consuming operating earnings, a common characteristic of units requiring management without high growth potential.

The units categorized as Dogs are candidates for divestiture or minimal investment, focusing instead on harvesting remaining value. You should watch for:

  • Fund step-downs and expirations totaling $673 million in Q3 2025.
  • The $40 million in cash and equivalents, which represents low-yielding trapped capital.
  • Any future write-downs or impairment charges related to acquired managers that fail to scale.
  • Operating expenses remaining flat year-over-year at $65.2 million in Q3 2025, indicating costs are not decreasing alongside maturing fund bases.

Finance: review the expected 2026 step-down forecast against the current $398 million debt load by next Tuesday.



P10, Inc. (PX) - BCG Matrix: Question Marks

You're looking at the parts of P10, Inc. that are in fast-growing markets but haven't yet captured the dominant market share you'd expect from a Cash Cow. These are the units demanding capital now, hoping to become future Stars. Honestly, they are burning cash to gain ground.

Impact Investing Solutions represents one such area. While P10, Inc. has a presence here, it's positioned as smaller relative to the core Private Equity (PE) business, which is the established engine. The market for impact-focused alternatives is definitely growing, meaning P10, Inc. must invest heavily to build out its relative share against more established players in this specific niche.

The New Cross-Border Offerings, specifically the recently integrated Qualitas Funds platform, fits this mold perfectly. This is a significant global expansion play, requiring substantial investment to scale its European presence. P10, Inc. completed this acquisition for an initial purchase price of $63 million in April 2025. Qualitas Funds brought approximately $1 billion in fee-paying assets under management (FPAUM) as of December 31, 2024. Integrating this platform and accelerating its growth across P10, Inc.'s global client base is a classic Question Mark investment.

The Venture Capital (VC) Segment, anchored by the TrueBridge strategy, is inherently high-growth but volatile. It requires continuous capital commitment to maintain relevance and capture market share in the access-constrained VC space. For the third quarter of 2025, the VC segment raised and deployed $12 million in gross new fee-paying AUM. This deployment shows the cash consumption required to keep this high-potential segment moving forward.

The financial results from the third quarter of 2025 clearly show the cost of fueling this growth across the platform. While the overall Fee-Paying AUM grew robustly, the profitability metric that reflects current returns is under pressure, which is typical for Question Marks that are being heavily funded.

Segment Activity Q3 2025 Gross New Fee-Paying AUM Raised/Deployed (Millions USD) Context
Total Organic Fundraising & Deployment $915 Overall cash deployment to fuel growth across all strategies.
Private Equity Solutions $711 The core business, still requiring capital for growth.
Private Credit Solutions $192 Capital deployed into this growing asset class.
Venture Capital Solutions $12 Investment in the high-growth, volatile VC segment.

The pressure on current returns is evident when you look at the bottom line. For the third quarter ended September 30, 2025, P10, Inc.'s Adjusted Net Income (ANI) decreased 7% year-over-year, falling to $28.6 million from $30.8 million in Q3 2024. This decline in ANI, despite Fee-Related Revenue growing 4% year-over-year to $75.9 million, signals that high investment spending-the cost of trying to turn these Question Marks into Stars-is currently outweighing the immediate profit gains.

Here are the key financial markers reflecting the high-growth/low-return dynamic:

  • Fully Diluted ANI per share for Q3 2025 was $0.24, down from $0.26 in the prior year.
  • Total Fee-Paying Assets Under Management (FPAUM) reached $29.1 billion, a strong 17% increase year-over-year.
  • The company raised its full-year 2025 organic gross fundraising target to closer to $5 billion, up from the initial $4 billion guidance, confirming the high-growth market perception.
  • Operating Expenses in Q3 2025 were $65.2 million, remaining flat compared to Q3 2024, suggesting that while revenue grew, the investment required for these new areas is being managed carefully against the backdrop of the ANI decline.

Finance: draft 13-week cash view by Friday.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.